News & Events
Read more Esmee Koedoot Presents VitroScan’s Approach to Precision Oncology at LBSP TechTalk
17 March 2026
VitroScan presented at the March TechTalk at Leiden Bio Science Park, where Esmee Koedoot shared how the company is advancing precision oncology through predictive, patient-specific insights that support therapy selection to improve patient outcomes. The event brought together a diverse group of innovators from across the life sciences ecosystem, fostering valuable discussions and knowledge exchange.
Read more
Read more VitroScan Shares ChemoPredict Journey at Biotech Booster Annual Event
11 March 2026
CEO Willemijn Vader and PSC Chair Joris Schuurmans highlighted lessons learned in the ChemoPredict Biotech Booster project from scientific innovation towards a market-ready solution.
Read more
Read more A Major Milestone for VitroScan: ISO 15189 Compliance! 🎉
10 March 2026
As of March 2026, VitroScan is operating under an ISO 15189 compliant quality management system. This internationally recognized quality standard sets the benchmark for excellence in medical laboratories, ensuring that every clinical sample analysis meets the highest levels of quality, reliability, and regulatory compliance.
Read more
Read more Meet VitroScan at BioEurope Spring 2026
9 February 2026
Exciting news! VitroScan will be at BioEuropeSpring (March 23‑25, Lisbon). We’d love to connect and discuss how our ex vivo micro‑tumor testing can accelerate the development of your oncology assets.
Read more
Read more Biotech Booster Annual Event 2026 on March 10: Willemijn Vader and Joris Schuurmans will present ChemoPredict project journey
5 February 2026
Join Willemijn Vader, CEO at VitroScan, and Joris Schuurmans, Chair of the ChemoPredict project steering committee, at the Biotech Booster Annual Event on March 10.
Read more
Read more VitroScan at DxPx 2026
26 January 2026
Meet VitroScan at the DxPx conference, 5-6 February in Munich! Our CEO Willemijn Vader will represent VitroScan and will be available for in person meetings.
Read more
Read more VitroScan featured in Oncologie Up-to-date magazine
6 January 2026
VitroScan, known for its ex vivo 3D micro-tumor testing platform, has been highlighted in the latest issue of Oncologie Up-to-date, the Dutch medical scientific news magazine that reports on current developments in oncology .
Read more
Read more Meet VitroScan!
1 November 2025
In this video, Willemijn Vader explains how our ChemoPredict platform supports better treatment decisions.
Read more
Read more VitroScan will be pitching at the Dutch Life Sciences Day investors forum
31 October 2025
Meet VitroScan at the Dutch Life Sciences Conference 2025 where Willemijn Vader will be pitching at the investors forum.
Read more
Read more VitroScan awarded Kansen voor West grant to advance ex vivo tumor testing for next-generation immunotherapies
29 October 2025
VitroScan awarded 'Kansen voor West'-grant to advance ex vivo tumor testing for next-generation immunotherapies
Read more
Read more VitroScan is presenting at SITC 2025
15 October 2025
VitroScan will be presenting at the 40th Anniversary Annual Meeting of the Society of Immunology of Cancer.
Read more
Read more VitroScan will be present at Bio-Europe 2025
1 October 2025
VitroScan will be present and available to discuss how our testing solutions can help you reduce risk and maximize success in your drug development process.
Read more